Hemispherx Biopharma has filed an amended NDA with ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica) for the use of Alferon N injection to treat Hepatitis C patients in Argentina. ANMAT has previously approved ...
Tags: Hemispherx Biopharma, Amended NDA, Alferon N Injection, ANMAT
Ind-Swift, an Indian pharmaceutical company, in collaboration with its marketing partner Wockhardt UK launched the generic formulations of atorvastatin drug in UK on the first day of its patent expiry. Atorvastatin (lipitor) is used for ...
Tags: atorvastatin, lipitor, Ind-Swift